Tranmep en es it fr

Tranmep Brand names, Tranmep Analogs

Tranmep Brand Names Mixture

  • No information avaliable

Tranmep Chemical_Formula


Tranmep RX_link

No information avaliable

Tranmep fda sheet

Tranmep msds (material safety sheet)

Tranmep Synthesis Reference

No information avaliable

Tranmep Molecular Weight

309.469 g/mol

Tranmep Melting Point

< 25 oC

Tranmep H2O Solubility

Soluble as HCl salt

Tranmep State


Tranmep LogP


Tranmep Dosage Forms

Tablets (oral, 1 mg)

Tranmep Indication

Used for the symptomatic treatment of parkinsonism.

Tranmep Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Tranmep Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Tranmep side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Tranmep Patient Information

Tranmep Organisms Affected

Humans and other mammals